Windtree Therapeutics, Inc. ( WINT ) shares are racing higher Friday after the company requested the withdrawal of its Registration Statement previously filed with the SEC. 

The Details:

Windtree filed the withdrawal request as it does not intend to pursue, at this time, the public offering to which the Registration Statement relates.

Read Next: DexCom Stock Drops After Mixed Q2 Results, Weak Forward Guidance

The company announced the closing of financing through a private placement of its Series C preferred stock on Monday. 

“We are pleased to announce this private placement and the equity line of credit as they accomplish several important objectives for the company,” said Craig Fraser, CEO.

“First, the private placement delivers needed capital to support company operations, including the active Phase 2b clinical trial for istaroxime in cardiogenic shock. Second, the transaction fully converted and eliminated senior notes, including senior secured notes we used as bridge financing over the past several months eliminating this debt from our balance sheet.” 

Windtree shares are blasting higher on heavy volume Friday with more than 9 million shares changing hands before the opening bell. 

How To Buy WINT Stock:

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Windtree Therapeutics’ case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

WINT Price Action: According to Benzinga Pro, Windtree shares are up 166% at $8.77 at the time of publication Friday.

Read Also:

What’s Going On With Super Micro Computer Stock?

Image: Moondance from Pixabay